¥2,921.50
1.07%
Tokyo, Oct 02, 02:50 pm JST. Closed.
ISIN
JP3268950007
Symbol
7459

MediPal Stock price

¥2,920.00
+5.00 0.17% 1M
-95.00 3.15% 6M
+150.00 5.42% YTD
+392.50 15.53% 1Y
+414.50 16.54% 3Y
+815.00 38.72% 5Y
+1,148.00 64.79% 10Y
+555.00 23.47% 20Y
Tokyo, Closing price Fri, Oct 02 2026
-33.00 1.12%
Compare with Peer Group
ISIN
JP3268950007
Symbol
7459

Is MediPal a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
¥535.7b
Enterprise Value
¥245.8b
Net debt
positive
Cash
¥289.9b
Shares outstanding
204.7m
Valuation
P/E
12.8
P/S | estimate
0.1 | 0.1
EV/Sales | estimate
0.1 | 0.1
EV/FCF | ex SBC
- | -
P/B
0.8
Dividends
DPS
¥88.00
Yield 1Y | 5Y
3.0% | 2.7%
Growth 1Y | 5Y
33.3% | 14.9%
Payout 1Y | 3Y
31.9% | 31.6%
Increased
8 Years
Financials
Revenue | estimate
¥3.9t | ¥4.0t
EBITDA
¥66.3b
EBIT
¥43.0b
Net Income
¥46.6b
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
4.2% | 3.9%
EBITDA
-5.2%
EBIT
-23.8%
Net Income
14.0%
Free Cash Flow
-
Margin
Gross
6.8%
EBITDA
1.7%
EBIT
1.1%
Net
1.2%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
33.9%
Return on Equity
6.5%
ROCE
5.1%
ROIC
5.0%
Debt/Equity
0.0
More
EPS
¥227.6
FCF per Share
-
Short interest
-
Employees
13k
Rev per Employee
¥292.3m

MediPal Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a MediPal forecast:

6x Hold
55%
5x Sell
45%

Analyst Opinions

11 Analysts have issued a MediPal forecast:

Hold
55%
Sell
45%

Financial data from MediPal

Jun '26
+/-
%
3,861,698 3,861,698
4% 4%
100%
- Direct Costs 3,599,655 3,599,655
4% 4%
93%
262,043 262,043
2% 2%
7%
- Selling and Administrative Expenses 195,786 195,786
4% 4%
5%
- Research and Development Expense - -
-
-
66,255 66,255
5% 5%
2%
- Depreciation and Amortization 23,283 23,283
72% 72%
1%
EBIT (Operating Income) EBIT 42,972 42,972
24% 24%
1%
Net Profit 46,594 46,594
14% 14%
1%

In millions JPY.

Don't miss a Thing! We will send you all news about MediPal directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 13,061 full-time employees. The firm operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The firm also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.

Head office Japan
CEO Mr. Watanabe
Employees 13,061
Website www.medipal.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today